Antimicrobial compositions and uses thereof

US11065223B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11065223-B2
Application numberUS-201716078735-A
CountryUS
Kind codeB2
Filing dateFeb 21, 2017
Priority dateFeb 22, 2016
Publication dateJul 20, 2021
Grant dateJul 20, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In some aspects, provided herein are antimicrobial compositions comprising partially esterified polygalacturonic acid and certain fatty acids (e.g., caprylic acid). In some embodiments, the antimicrobial composition may be administered (e.g., topically or orally) to a subject, such as a human patient to treat an infection (e.g., an infection comprising a biofilm). In some aspects, improved catheters are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. An antimicrobial composition comprising: from about 0.5% to about 3% (w/w) of a polygalacturonic acid mixture and from greater than 0.1% to about 5% (w/w) of a C 6-12 fatty acid; wherein the ratio of the polygalacturonic acid mixture consists of esterified polygalacturonic acid and de-esterified polygalacturonic acid in an amount of at least about 50% de-esterified polygalacturonic acid. 2. The antimicrobial composition of claim 1 , wherein the C 6-12 fatty acid is a C 6-12 saturated fatty acid or a C 6-12 alkanoic acid. 3. The antimicrobial composition of claim 2 , wherein the C 6-12 fatty acid is a C 6-10 saturated fatty acid or a C 6-10 alkanoic acid. 4. The antimicrobial composition of claim 2 , wherein the C 6-12 fatty acid is hexanoic acid, octanoic acid, decanoic acid, dodecanoic acid, caprylic acid (octanoic acid), caproic acid, or lauric acid. 5. The antimicrobial composition of claim 4 , wherein the C 6-12 fatty acid is caprylic acid (octanoic acid). 6. The antimicrobial composition of claim 1 , wherein the composition comprises from about 0.2% to about 5% of the fatty acid. 7. The antimicrobial composition of claim 6 , wherein the composition comprises from about 0.3% to about 5% of the fatty acid. 8. The antimicrobial composition of claim 7 , wherein the composition comprises from about 0.4% to about 5% of the fatty acid. 9. The antimicrobial composition of claim 6 , wherein the composition comprises from about 0.4% to about 3% of the fatty acid. 10. The antimicrobial composition of claim 1 , wherein the fatty acid is protonated or a free acid. 11. The antimicrobial composition of claim 1 , wherein the antimicrobial composition has a pH of about 4.8 or less. 12. The antimicrobial composition of claim 11 , wherein the antimicrobial composition has a pH of about 3.7-4.8. 13. The antimicrobial composition of any one of claim 12 , wherein the antimicrobial composition has a pH of about 4-4.7. 14. The antimicrobial composition of claim 1 , wherein said amount is at least about 70% de-esterified polygalacturonic acid, wherein the de-esterified polygalacturonic acid is substantially deprotonated. 15. The antimicrobial composition of claim 1 , wherein said amount is at least about 85% de-esterified polygalacturonic acid, wherein the de-esterified polygalacturonic acid is substantially deprotonated. 16. The antimicrobial composition of claim 1 , wherein the antimicrobial composition further comprises a peroxide. 17. The antimicrobial composition of claim 16 , wherein the peroxide is hydrogen peroxide. 18. The antimicrobial composition of claim 16 , wherein the hydrogen peroxide is present in the antimicrobial composition in an amount of from about 0.1% to about 3%. 19. The antimicrobial composition of claim 16 , wherein the hydrogen peroxide is present in the antimicrobial composition in an amount of from about 0.1% to about 1%. 20. The antimicrobial composition of claim 1 , wherein the antimicrobial composition further comprises one or more additional antimicrobial agent. 21. The antimicrobial composition of claim 20 , wherein the one or more additional antimicrobial agent is an antibiotic, an antiseptic, chlorhexidine, gendine, gardine, silver, nanosilver, silver sulfadiazine, polyhexamethylene biguanide (PHMB), a chelator, a C 1-4 alcohol, a nitric oxide donor, a quarternary ammonium antimicrobial, or mixtures thereof. 22. The antimicrobial composition of claim 21 , wherein the antimicrobial composition comprises the nitric oxide donor, and wherein the nitric oxide donor is a glyceryl nitrate, nitroprusside, nitrosoglutathione, a nitroso compound, nitrosothiol, nitrosocystein, nitrosoalbumin, nitro compounds, nitroaspiririn, isosorbide, diazeniumdiolate, nitrate, or nitrite. 23. The antimicrobial composition of claim 22 , wherein the glyceryl nitrate is glyceryl trinitrate (GTN). 24. The antimicrobial composition of claim 23 , wherein the antimicrobial composition comprises about 0.01-1% glyceryl trinitrate (GTN). 25. The antimicrobial composition of claim 21 , wherein the antibiotic is minocycline, rifampin, an aminoglycoside, quinolone, carbapenem, cephalosporin, glycopeptide, lipopeptide, lincosamide, macrolide, monobactam, nitrofuran, oxazolidinone, penicilin, polypeptide, sulfonamide, tetracycline, metronidazole, muciprocin, anti-mycobacterial compound, or chloramphenicol. 26. The antimicrobial composition of claim 21 , wherein the C 1-4 alcohol is ethanol. 27. The antimicrobial composition of claim 21 , wherein the chelator is mercaptoethane sulfonate (MeSNA), citrate, EDTA, EDDS, or N-acetyl cysteine. 28. The antimicrobial composition of claim 1 , wherein the antimicrobial composition further comprises an antibiotic. 29. The antimicrobial composition of claim 1 , wherein the antimicrobial composition further comprises an analgesic agent, an antiscarring agent, an anti-inflammatory agent, an anticoagulant, a fragrance, a moisturizer, glycerol, a silicone compound, a vitamin, humectant, a polymer, a lubricant, a tactile agent, a thickener, a gelling agent, an emollient, a surfactant, an emulsifier, a moisturizer, a coloring or tinting agent, or a fragrance. 30. The antimicrobial composition of claim 1 , wherein the solution comprises a pharmaceutically acceptable saline diluent. 31. The antimicrobial composition of claim 1 , wherein the antimicrobial composition is further defined as a pharmaceutical composition or comprises a pharmaceutically acceptable excipient. 32. The antimicrobial composition of claim 31 , wherein the antimicrobial composition comprises a protein. 33. The antimicrobial composition of claim 32 , wherein the protein is gelatin, a plasticized gelatin, an alginate, a chitosan, collagen, or a proteoglycan. 34. The antimicrobial composition of claim 33 , wherein the plasticized gelatin is glycerol-gelatin. 35. The antimicrobial composition of claim 33 , wherein the proteoglycan is hyaluronic acid. 36. The antimicrobial composition of claim 1 , wherein the antimicrobial composition comprises a cellulose and a glycerol. 37. The antimicrobial composition of claim 36 , wherein the cellulose is carboxymethyl cellulose or hydroxymethylcellulose. 38. The antimicrobial composition of claim 36 , wherein the glycerol is propylene glycol or glycerol. 39. The antimicrobial composition of claim 36 , wherein the antimicrobial composition comprises about 1-5% carboxymethyl cellulose and about 10-30% propylene glycol. 40. The antimicrobial composition of claim 1 , wherein the antimicrobial composition comprises about 0.5-2% pectinic acid, about 0.3-0.5% caprylic acid, and about 0.01-1% glyceryl trinitrate (GTN). 41. The antimicrobial composition of claim 1 , wherein the antimicrobial composition comprises about 1-1000 micrograms/ml glyceryl trinitrate and about 0.1-1% hydrogen peroxide. 42. The composition of claim 1 , wherein the antimicrobial composition is further defined as a catheter lock or flush solution. 43. The composition of claim 1 , wherein the composition comprises at least 0.75% or at least 1% of the polygalact

Assignees

Inventors

Classifications

  • with at least two inner passageways, a first one for irrigating and a second for evacuating (suction-irrigation systems A61M1/77; aspiration tips with fluid supply means A61M1/85; for negative pressure wound therapy A61M1/92) · CPC title

  • manually, e.g. by squeezing a bulb · CPC title

  • Peroxides · CPC title

  • Esters, e.g. nitroglycerine, selenocyanates · CPC title

  • Pectin; Derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11065223B2 cover?
In some aspects, provided herein are antimicrobial compositions comprising partially esterified polygalacturonic acid and certain fatty acids (e.g., caprylic acid). In some embodiments, the antimicrobial composition may be administered (e.g., topically or orally) to a subject, such as a human patient to treat an infection (e.g., an infection comprising a biofilm). In some aspects, improved cath…
Who is the assignee on this patent?
Univ Texas
What technology area does this patent fall under?
Primary CPC classification A61K31/20. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).